Stay updated on MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial
Sign up to get notified when there's something new on the MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial page.

Latest updates to the MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2; removed the previous funding/operating-status notice (Revision: v3.4.1).SummaryDifference0.7%

- Check21 days agoChange DetectedAdded a site-wide funding-status notice and updated the release version from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check28 days agoChange DetectedThe changes are UI-related: a 'Show glossary' option was added, color-coded indicators for changes were explained, and the latest Revision: v3.4.0 was introduced while the prior Revision: v3.3.4 label and the 'No FEAR Act Data' item were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

- Check42 days agoChange DetectedThe page history now includes a new Revision: v3.3.4, and the previous Revision: v3.3.3 has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedFooter updates show Revision: v3.3.3; the HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check85 days agoChange DetectedThe revision history shows a new entry for v3.3.2, replacing the previous v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial page.